Trial Profile
A Study of Bone Histomorphometry, Microarchitecture, and Matrix Structure in Patients Receiving Long-Term Alendronate or Risedronate.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Risedronic acid (Primary) ; Alendronic acid
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- Sponsors Procter & Gamble
- 14 Nov 2008 New trial record.